Your browser doesn't support javascript.
loading
SB332235, a CXCR2 antagonist, ameliorates thioacetamide-induced hepatic encephalopathy through modulation of the PI3K/AKT pathways in rats.
Abdelaziz, Rania R; Abdelrahman, Rehab S; Abdelmageed, Marwa E.
Afiliação
  • Abdelaziz RR; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, 35516 Mansoura, Egypt.
  • Abdelrahman RS; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, 35516 Mansoura, Egypt; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Taibah University, Al-Madina Al-Munawwarah, 30001, Saudi Arabia.
  • Abdelmageed ME; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, 35516 Mansoura, Egypt. Electronic address: merro20102002@yahoo.com.
Neurotoxicology ; 92: 110-121, 2022 09.
Article em En | MEDLINE | ID: mdl-35961375

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encefalopatia Hepática / Fármacos Neuroprotetores Limite: Animals Idioma: En Revista: Neurotoxicology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Egito

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encefalopatia Hepática / Fármacos Neuroprotetores Limite: Animals Idioma: En Revista: Neurotoxicology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Egito